查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1587498

幹細胞市場規模、佔有率、趨勢分析報告：2025-2030 年按產品、應用、技術、療法、最終用途、地區和細分市場進行的預測

Stem Cells Market Size, Share & Trends Analysis Report By Product (Adult Stem Cells, Human Embryonic Stem Cells), By Application (Regenerative Medicine), By Technology, Therapy, End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

幹細胞市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球幹細胞市場規模將達到288.9億美元，2025年至2030年複合年成長率為11.41%。

幹細胞是可以分化成各種其他細胞並最終形成器官和組織的細胞。多年來，人們進行了​​大量研究來評估幹細胞的真正潛力，從而在遺傳疾病治療、神經系統疾病、腫瘤學和器官再生等領域中廣泛應用。推動這一市場發展的是銀行數量的增加、對增強這些產品的治療潛力的日益關注以及對再生醫學開發的廣泛研究。

對再生療法的日益關注是市場擴張的驅動力。 iPS 細胞在創建客製化細胞療法方面越來越受歡迎，為再生醫學開闢了新的可能性。例如，2020 年 9 月，杜克-新加坡國立大學和莫納什大學的研究人員發現了第一個可以幫助治療懷孕期間胎盤問題的幹細胞。研究人員設計了一種新方法來製造可用於生成胎盤細胞的人工絨毛幹細胞。這項研究將有助於開發體外人類胎盤模型，並為未來的治療鋪平道路。

此外，COVID-19 正在充當推動市場成長的催化劑。包括美國、中國和伊朗在內的多個國家已開始使用細胞療法治療 COVID-19感染疾病進行臨床試驗。此外，使用細胞療法治療 COVID-19 患者取得了優異的效果，這也推動了市場的擴張。 2020 年 1 月，中國北京的研究小組對患者進行了一項試驗，看看幹細胞療法是否有助於對抗 COVID-19。這項研究發現，在治療的初始試驗期間，向 COVID-19 患者靜脈注射臨床級 MSC 可以改善他們的功能結果並加速康復。

癌症盛行率的增加是導致預測期內成長的主要因素之一。聯合治療和化療在癌症治療中的失敗正在推動成長，因為醫生的偏好從此類治療轉向自體和同種異體幹細胞療法。此外，主要市場相關人員和政府機構繼續投資於癌症研究。例如，2021年11月，加州再生醫學研究所撥款400萬美元用於治療急性淋巴性白血病（ALL）、慢性淋巴性白血病（CLL）和套細胞淋巴瘤（MCL）患者。

使用和採用基於細胞的療法的新技術的引入預計將在預測期內推動成長。成體幹細胞和臍帶血處理和儲存的自動化是預計將對市場成長產生積極影響的關鍵技術。例如，許多科學家都致力於核准使用幹細胞治療多種疾病的安全且成功的療法。 2021年，Biotech Cellino等公司投資了7,500萬美元，致力於融合人工智慧技術，開發自動化幹細胞製造。

另一方面，高昂的處理成本預計將阻礙市場成長。例如，幹細胞研究公司 Bioinformant 報告稱，每位患者的幹細胞治療費用在 5,000 美元到 8,000 美元之間，有些病例的費用超過 25,000 美元，具體取決於手術的複雜程度。此外，對幹細胞研究活動的監管傳統上阻礙了胚胎幹細胞的生長，導致儘管有好處，但其在整個市場中所佔的佔有率很小。

幹細胞市場報告亮點

  • 成體幹細胞在2024年佔據市場最大的銷售佔有率，為70.76%，因為它們不像胚胎幹細胞那樣涉及胚胎的破壞。
  • 由於政府對再生醫學開發的資助增加，再生醫學在 2024 年佔據市場主導地位。
  • 2024年，電池收購領域的收益佔有率最高，為33.43%。胚胎幹細胞的發現為開發多種疾病的新療法鋪平了道路。
  • 2024年，同種療法領域的收益佔有率最高，達59.33%。
  • 2024 年，製藥和生技公司細分市場的收益佔有率最大，為 54.19%。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制與挑戰分析
  • 產業分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19 影響分析

第4章 產品經營分析

  • 幹細胞市場：產品波動分析
  • 成體幹細胞（ASC）
    • 成體幹細胞 (ASC) 市場，2018-2030
    • 造血作用
    • 間質
    • 神經的
    • 上皮/皮膚
    • 其他
  • 人類胚胎幹細胞（HESC）
    • 人類胚胎幹細胞（HESC）市場，2018-2030
  • 誘導性多功能幹細胞(iPSC)
    • 誘導性多功能幹細胞(iPSC) 市場，2018-2030
  • 微小胚胎幹細胞
    • 最小胚胎幹細胞市場，2018-2030

第5章 應用業務分析

  • 幹細胞市場：應用變化分析
  • 再生醫學
    • 再生醫學市場，2018-2030
    • 神經病學
    • 整形外科
    • 腫瘤學
    • 血液學
    • 心血管疾病和心肌梗塞
    • 受傷
    • 糖尿病
    • 肝臟疾病
    • 失禁
    • 其他
  • 藥物發現與開發
    • 藥物發現與開發市場，2018-2030

第6章技術業務分析

  • 幹細胞市場：技術波動分析
  • 細胞採集
    • 2018-2030 年細胞採集市場
    • 骨髓採集
    • 臍帶血
    • 血漿分離術
  • 細胞生產
    • 2018-2030年電池片生產市場
    • 用於治療目的的克隆
    • 體外受精
    • 細胞培養
    • 分離
  • 冷凍保存
    • 冷凍保存市場，2018-2030
  • 擴張/繼代培養
    • 擴張和繼代培養市場，2018-2030

第7章治療業務分析

  • 幹細胞市場：治療變異分析
  • 自體移植
    • 自體移植市場，2018-2030
  • 同種異體的
    • 同種異體市場，2018-2030

第8章 應用業務分析

  • 幹細胞市場：應用變化分析
  • 感染疾病
    • 感染疾病市場，2018-2030
  • 免疫學
    • 免疫學市場，2018-2030
  • 腫瘤學
    • 腫瘤市場，2018-2030
  • 幹細胞
    • 幹細胞市場，2018-2030
  • 神經生物學
    • 神經生物學市場，2018-2030
  • 其他
    • 其他應用市場，2018-2030

第 9 章最終用途業務分析

  • 幹細胞市場：最終用途變化分析
  • 製藥和生物技術公司
    • 製藥和生物技術公司市場，2018-2030
  • 醫院和細胞庫
    • 醫院和細胞庫市場，2018-2030
  • 學術研究所
    • 學術研究機構市場，2018-2030

第10章區域業務分析

  • 2025 年及 2030 年幹細胞市場佔有率（按地區）
  • 北美洲
    • 北美幹細胞市場，2018-2030
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 歐洲幹細胞市場，2018-2030
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太幹細胞市場，2018-2030
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 拉丁美洲幹細胞市場，2018-2030
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 中東和非洲幹細胞市場，2018-2030
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第11章競爭格局

  • 公司分類
  • 策略規劃
  • 2024 年企業市場分析
  • 公司簡介/上市公司
    • Thermo Fisher Scientific, Inc.
    • STEMCELL Technologies Inc.
    • Merck KGaA
    • CellGenix GmbH
    • PromoCell GmbH
    • Takara Holdings, Inc.
    • Lonza
    • Cellular Engineering Technologies
    • ATCC
    • AcceGen
    • Cell Applications, Inc.
    • Bio-Techne
Product Code: 978-1-68038-130-6

Stem Cells Market Growth & Trends:

The global stem cells market size is expected to reach USD 28.89 billion by 2030, registering a CAGR of 11.41% from 2025 to 2030, according to a new report by Grand View Research, Inc. Stem cells are cells that can differentiate into a variety of other cells, eventually forming organs or tissues. Many studies have been conducted over the years to assess the true potential of stem cells, leading to a variety of applications in the fields of genetic disease treatment, neurological disorders, oncology, and organ regeneration. The market is driven by the rising number of banks, growing focus on increasing therapeutic potential of these products, and extensive research for the development of regenerative medicines, among other factors.

The growing focus on regenerative therapies is fueling market expansion. iPSCs are becoming increasingly popular for the creation of customized cellular therapies, and opening up new possibilities in regenerative medicine. For instance, in September 2020, researchers from Duke-NUS and Monash University discovered the first stem cell that can aid in the treatment of placenta issues during pregnancy. The researchers devised a new method for producing induced trophoblast stem cells that can be used to generate placenta cells. The research will aid in the development of an in-vitro human placenta model and pave the way for future therapies.

Moreover, COVID-19 is acting as a catalyst for promoting the market growth. Several countries such as U.S., China, and Iran, have started conducting clinical trials using cellular therapies for treatment of COVID-19 infections. Furthermore, the use of cell therapy in the treatment of COVID-19 patients has yielded excellent results, which is fueling market expansion. In January 2020, a group of researchers in Beijing, China, tested stem cell treatment on patients to see if it was beneficial against COVID-19. The study found that administering intravenous clinical-grade MSCs to COVID-19 patients during first trial of treatment, improved their functional results and promoted enhanced recovery.

Increasing prevalence of cancer is one of the key factors contributing to the growth over the forecast period. Failure of combination therapy and chemotherapy for treatment of cancer has led to the shift in preference of physicians from such therapies to autologous and allogeneic stem cell therapy, thereby boosting the growth. Moreover, key market players and the government bodies are continuously investing in cancer research. For instance, in November 2021, California Institute for Regenerative Medicine invested USD 4 million in therapy targeting patients with acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL)

Introduction of novel technologies for the usage and adoption of cell based therapy is expected to boost the growth over the forecast period. Automation in adult stem cell & cord blood processing and storage are the key technologies expected to positively influence the market growth. For instance, various scientists are aiming for the approval of safe, and successful treatments using stem cells in a broad range of diseases. In 2021, companies such as Biotech Cellino invested USD 75 million in an effort to merge Artificial Intelligence technology for the development of automated stem cell manufacturing, that has the ability to regularizing access to cell treatments while aiming to be cost effective.

On the other hand, high cost of therapy is expected to hinder the market growth. For example, Bio informant, a stem cell research firm, reported that the cost of stem cell therapy ranges between USD 5,000 and USD 8,000 per patient, with some cases costing as much as USD 25,000 or more depending on the complexity of the procedure. Furthermore, restrictions on stem cell research activities have traditionally hampered embryonic stem cell growth, resulting in a meager share of the total market despite its advantages.

Stem Cells Market Report Highlights:

  • Adult stem cells held the largest revenue share of 70.76% of the market in 2024 as these cells do not involve the destruction of embryos, which is the case in embryonic stem cells
  • Regenerative medicine dominated the market in 2024 owing to increasing funding by the government for the development of regenerative medicines
  • The cell acquisition segment captured the highest revenue share of 33.43% of the market in 2024. The discovery of embryonic stem cells has paved the way for the development of novel treatments for several diseases
  • The allogenic therapy segment captured the largest revenue share of 59.33% in 2024 with regard to revenue generation
  • The pharmaceutical and biotechnology companies segment captured the largest revenue share of 54.19% in 2024

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product Segment
    • 1.1.2. Application Segment
    • 1.1.3. Technology Segment
    • 1.1.4. Therapy Segment
    • 1.1.5. End-use Segment
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List Of Secondary Sources
  • 1.8. List Of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Ongoing Developments In Regenerative Medicine
      • 3.2.1.2. Rising Funds For Accelerating Stem Cell Research
      • 3.2.1.3. Growing Demand For Stem Cell Banking
      • 3.2.1.4. Increasing Prevalence Of Genetic Disorders and Cancer
    • 3.2.2. Market Restraint And Challenges Analysis
      • 3.2.2.1. Ethical Concern Related To Stem Cell Research
      • 3.2.2.2. Lack Of A Well-Defined Regulatory Framework In Certain Applications Of Stem Cell
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Stem Cells Market: Product Movement Analysis
  • 4.2. Adult Stem Cells (ASCs)
    • 4.2.1. Adult Stem Cells (ASCs) Market, 2018 - 2030 (USD Billion)
    • 4.2.2. Hematopoietic
      • 4.2.2.1. Hematopoietic Market, 2018 - 2030 (USD Billion)
    • 4.2.3. Mesenchymal
      • 4.2.3.1. Mesenchymal Market, 2018 - 2030 (USD Billion)
    • 4.2.4. Neural
      • 4.2.4.1. Neural Market, 2018 - 2030 (USD Billion)
    • 4.2.5. Epithelial/Skin
      • 4.2.5.1. Epithelial/Skin Market, 2018 - 2030 (USD Billion)
    • 4.2.6. Others
      • 4.2.6.1. Others Market, 2018 - 2030 (USD Billion)
  • 4.3. Human Embryonic Stem Cells (HESCs)
    • 4.3.1. Human Embryonic Stem Cells (HESCs) Market, 2018 - 2030 (USD Billion)
  • 4.4. Induced Pluripotent Stem Cells (iPSCs)
    • 4.4.1. Induced Pluripotent Stem Cells (iPSCs) Market, 2018 - 2030 (USD Billion)
  • 4.5. Very Small Embryonic Like Stem Cells
    • 4.5.1. Very Small Embryonic Like Stem Cells Market, 2018 - 2030 (USD Billion)

Chapter 5. Application Business Analysis

  • 5.1. Stem Cells Market: Application Movement Analysis
  • 5.2. Regenerative Medicine
    • 5.2.1. Regenerative Medicine Market, 2018 - 2030 (USD Billion)
    • 5.2.2. Neurology
      • 5.2.2.1. Neurology Market, 2018 - 2030 (USD Billion)
    • 5.2.3. Orthopedics
      • 5.2.3.1. Orthopedics Market, 2018 - 2030 (USD Billion)
    • 5.2.4. Oncology
      • 5.2.4.1. Oncology Market, 2018 - 2030 (USD Billion)
    • 5.2.5. Hematology
      • 5.2.5.1. Hematology Market, 2018 - 2030 (USD Billion)
    • 5.2.6. Cardiovascular and Myocardial Infraction
      • 5.2.6.1. Cardiovascular and Myocardial Infraction Market, 2018 - 2030 (USD Billion)
    • 5.2.7. Injuries
      • 5.2.7.1. Injuries Market, 2018 - 2030 (USD Billion)
    • 5.2.8. Diabetes
      • 5.2.8.1. Diabetes Market, 2018 - 2030 (USD Billion)
    • 5.2.9. Liver Disorder
      • 5.2.9.1. Liver Disorder Market, 2018 - 2030 (USD Billion)
    • 5.2.10. Incontinence
      • 5.2.10.1. Incontinence Market, 2018 - 2030 (USD Billion)
    • 5.2.11. Others
      • 5.2.11.1. Others Market, 2018 - 2030 (USD Billion)
  • 5.3. Drug Discovery and Development
    • 5.3.1. Drug Discovery and Development Market, 2018 - 2030 (USD Billion)

Chapter 6. Technology Business Analysis

  • 6.1. Stem Cells Market: Technology Movement Analysis
  • 6.2. Cell Acquisition
    • 6.2.1. Cell Acquisition Market, 2018 - 2030 (USD Billion)
    • 6.2.2. Bone Marrow Harvest
      • 6.2.2.1. Bone Marrow Harvest Market, 2018 - 2030 (USD Billion)
    • 6.2.3. Umbilical Blood Cord
      • 6.2.3.1. Umbilical Blood Cord Market, 2018 - 2030 (USD Billion)
    • 6.2.4. Apheresis
      • 6.2.4.1. Apheresis Market, 2018 - 2030 (USD Billion)
  • 6.3. Cell Production
    • 6.3.1. Cell Production Market, 2018 - 2030 (USD Billion)
    • 6.3.2. Therapeutic Cloning
      • 6.3.2.1. Therapeutic Cloning Market, 2018 - 2030 (USD Billion)
    • 6.3.3. In-vitro Fertilization
      • 6.3.3.1. In-vitro Fertilization Market, 2018 - 2030 (USD Billion)
    • 6.3.4. Cell Culture
      • 6.3.4.1. Cell Culture Market, 2018 - 2030 (USD Billion)
    • 6.3.5. Isolation
      • 6.3.5.1. Isolation Market, 2018 - 2030 (USD Billion)
  • 6.4. Cryopreservation
    • 6.4.1. Cryopreservation Market, 2018 - 2030 (USD Billion)
  • 6.5. Expansion and Sub-Culture
    • 6.5.1. Expansion and Sub-Culture Market, 2018 - 2030 (USD Billion)

Chapter 7. Therapy Business Analysis

  • 7.1. Stem Cells Market: Therapy Movement Analysis
  • 7.2. Autologous
    • 7.2.1. Autologous Market, 2018 - 2030 (USD Billion)
  • 7.3. Allogeneic
    • 7.3.1. Allogeneic Market, 2018 - 2030 (USD Billion)

Chapter 8. Application Business Analysis

  • 8.1. Stem Cells Market: Application Movement Analysis
  • 8.2. Infectious Diseases
    • 8.2.1. Infectious Diseases Market, 2018 - 2030 (USD Billion)
  • 8.3. Immunology
    • 8.3.1. Immunology Market, 2018 - 2030 (USD Billion)
  • 8.4. Oncology
    • 8.4.1. Oncology Market, 2018 - 2030 (USD Billion)
  • 8.5. Stem Cells
    • 8.5.1. Stem Cells Market, 2018 - 2030 (USD Billion)
  • 8.6. Neurobiology
    • 8.6.1. Neurobiology Market, 2018 - 2030 (USD Billion)
  • 8.7. Others
    • 8.7.1. Other Applications Market, 2018 - 2030 (USD Billion)

Chapter 9. End Use Business Analysis

  • 9.1. Stem Cells Market: End-use Movement Analysis
  • 9.2. Pharmaceutical and Biotechnology Companies
    • 9.2.1. Pharmaceutical and Biotechnology Companies Market, 2018 - 2030 (USD Billion)
  • 9.3. Hospitals & Cell Banks
    • 9.3.1. Hospitals & Cell Banks Market, 2018 - 2030 (USD Billion)
  • 9.4. Academic & Research Institutes
    • 9.4.1. Academic & Research Institutes Market, 2018 - 2030 (USD Billion)

Chapter 10. Regional Business Analysis

  • 10.1. Stem Cells Market Share By Region, 2025 & 2030
  • 10.2. North America
    • 10.2.1. North America Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.2.2. U.S.
      • 10.2.2.1. Key Country Dynamics
      • 10.2.2.2. Target Disease Prevalence
      • 10.2.2.3. Competitive Scenario
      • 10.2.2.4. Regulatory Framework
      • 10.2.2.5. U.S. Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.2.3. Canada
      • 10.2.3.1. Key Country Dynamics
      • 10.2.3.2. Target Disease Prevalence
      • 10.2.3.3. Competitive Scenario
      • 10.2.3.4. Regulatory Framework
      • 10.2.3.5. Canada Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.2.4. Mexico
      • 10.2.4.1. Key Country Dynamics
      • 10.2.4.2. Target Disease Prevalence
      • 10.2.4.3. Competitive Scenario
      • 10.2.4.4. Regulatory Framework
      • 10.2.4.5. Mexico Stem Cells Market, 2018 - 2030 (USD Billion)
  • 10.3. Europe
    • 10.3.1. Europe Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.3.2. UK
      • 10.3.2.1. Key Country Dynamics
      • 10.3.2.2. Target Disease Prevalence
      • 10.3.2.3. Competitive Scenario
      • 10.3.2.4. Regulatory Framework
      • 10.3.2.5. UK Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.3.3. Germany
      • 10.3.3.1. Key Country Dynamics
      • 10.3.3.2. Target Disease Prevalence
      • 10.3.3.3. Competitive Scenario
      • 10.3.3.4. Regulatory Framework
      • 10.3.3.5. Germany Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.3.4. France
      • 10.3.4.1. Key Country Dynamics
      • 10.3.4.2. Target Disease Prevalence
      • 10.3.4.3. Competitive Scenario
      • 10.3.4.4. Regulatory Framework
      • 10.3.4.5. France Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.3.5. Italy
      • 10.3.5.1. Key Country Dynamics
      • 10.3.5.2. Target Disease Prevalence
      • 10.3.5.3. Competitive Scenario
      • 10.3.5.4. Regulatory Framework
      • 10.3.5.5. Italy Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.3.6. Spain
      • 10.3.6.1. Key Country Dynamics
      • 10.3.6.2. Target Disease Prevalence
      • 10.3.6.3. Competitive Scenario
      • 10.3.6.4. Regulatory Framework
      • 10.3.6.5. Spain Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.3.7. Denmark
      • 10.3.7.1. Key Country Dynamics
      • 10.3.7.2. Target Disease Prevalence
      • 10.3.7.3. Competitive Scenario
      • 10.3.7.4. Regulatory Framework
      • 10.3.7.5. Denmark Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.3.8. Sweden
      • 10.3.8.1. Key Country Dynamics
      • 10.3.8.2. Target Disease Prevalence
      • 10.3.8.3. Competitive Scenario
      • 10.3.8.4. Regulatory Framework
      • 10.3.8.5. Sweden Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.3.9. Norway
      • 10.3.9.1. Key Country Dynamics
      • 10.3.9.2. Target Disease Prevalence
      • 10.3.9.3. Competitive Scenario
      • 10.3.9.4. Regulatory Framework
      • 10.3.9.5. Norway Stem Cells Market, 2018 - 2030 (USD Billion)
  • 10.4. Asia Pacific
    • 10.4.1. Asia Pacific Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.4.2. Japan
      • 10.4.2.1. Key Country Dynamics
      • 10.4.2.2. Target Disease Prevalence
      • 10.4.2.3. Competitive Scenario
      • 10.4.2.4. Regulatory Framework
      • 10.4.2.5. Japan Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.4.3. China
      • 10.4.3.1. Key Country Dynamics
      • 10.4.3.2. Target Disease Prevalence
      • 10.4.3.3. Competitive Scenario
      • 10.4.3.4. Regulatory Framework
      • 10.4.3.5. China Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.4.4. India
      • 10.4.4.1. Key Country Dynamics
      • 10.4.4.2. Target Disease Prevalence
      • 10.4.4.3. Competitive Scenario
      • 10.4.4.4. Regulatory Framework
      • 10.4.4.5. India Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.4.5. Australia
      • 10.4.5.1. Key Country Dynamics
      • 10.4.5.2. Target Disease Prevalence
      • 10.4.5.3. Competitive Scenario
      • 10.4.5.4. Regulatory Framework
      • 10.4.5.5. Australia Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.4.6. Thailand
      • 10.4.6.1. Key Country Dynamics
      • 10.4.6.2. Target Disease Prevalence
      • 10.4.6.3. Competitive Scenario
      • 10.4.6.4. Regulatory Framework
      • 10.4.6.5. Thailand Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.4.7. South Korea
      • 10.4.7.1. Key Country Dynamics
      • 10.4.7.2. Target Disease Prevalence
      • 10.4.7.3. Competitive Scenario
      • 10.4.7.4. Regulatory Framework
      • 10.4.7.5. South Korea Stem Cells Market, 2018 - 2030 (USD Billion)
  • 10.5. Latin America
    • 10.5.1. Latin America Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.5.2. Brazil
      • 10.5.2.1. Key Country Dynamics
      • 10.5.2.2. Target Disease Prevalence
      • 10.5.2.3. Competitive Scenario
      • 10.5.2.4. Regulatory Framework
      • 10.5.2.5. Brazil Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.5.3. Argentina
      • 10.5.3.1. Key Country Dynamics
      • 10.5.3.2. Target Disease Prevalence
      • 10.5.3.3. Competitive Scenario
      • 10.5.3.4. Regulatory Framework
      • 10.5.3.5. Argentina Stem Cells Market, 2018 - 2030 (USD Billion)
  • 10.6. MEA
    • 10.6.1. MEA Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.6.2. South Africa
      • 10.6.2.1. Key Country Dynamics
      • 10.6.2.2. Target Disease Prevalence
      • 10.6.2.3. Competitive Scenario
      • 10.6.2.4. Regulatory Framework
      • 10.6.2.5. South Africa Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.6.3. Saudi Arabia
      • 10.6.3.1. Key Country Dynamics
      • 10.6.3.2. Target Disease Prevalence
      • 10.6.3.3. Competitive Scenario
      • 10.6.3.4. Regulatory Framework
      • 10.6.3.5. Saudi Arabia Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.6.4. UAE
      • 10.6.4.1. Key Country Dynamics
      • 10.6.4.2. Target Disease Prevalence
      • 10.6.4.3. Competitive Scenario
      • 10.6.4.4. Regulatory Framework
      • 10.6.4.5. UAE Stem Cells Market, 2018 - 2030 (USD Billion)
    • 10.6.5. Kuwait
      • 10.6.5.1. Key Country Dynamics
      • 10.6.5.2. Target Disease Prevalence
      • 10.6.5.3. Competitive Scenario
      • 10.6.5.4. Regulatory Framework
      • 10.6.5.5. Kuwait Stem Cells Market, 2018 - 2030 (USD Billion)

Chapter 11. Competitive Landscape

  • 11.1. Company Categorization
  • 11.2. Strategy Mapping
  • 11.3. Company Market Position Analysis, 2024
  • 11.4. Company Profiles/Listing
    • 11.4.1. Thermo Fisher Scientific, Inc.
      • 11.4.1.1. Overview
      • 11.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 11.4.1.3. Product Benchmarking
      • 11.4.1.4. Strategic Initiatives
    • 11.4.2. STEMCELL Technologies Inc.
      • 11.4.2.1. Overview
      • 11.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 11.4.2.3. Product Benchmarking
      • 11.4.2.4. Strategic Initiatives
    • 11.4.3. Merck KGaA
      • 11.4.3.1. Overview
      • 11.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 11.4.3.3. Product Benchmarking
      • 11.4.3.4. Strategic Initiatives
    • 11.4.4. CellGenix GmbH
      • 11.4.4.1. Overview
      • 11.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 11.4.4.3. Product Benchmarking
      • 11.4.4.4. Strategic Initiatives
    • 11.4.5. PromoCell GmbH
      • 11.4.5.1. Overview
      • 11.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 11.4.5.3. Product Benchmarking
      • 11.4.5.4. Strategic Initiatives
    • 11.4.6. Takara Holdings, Inc.
      • 11.4.6.1. Overview
      • 11.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 11.4.6.3. Product Benchmarking
      • 11.4.6.4. Strategic Initiatives
    • 11.4.7. Lonza
      • 11.4.7.1. Overview
      • 11.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 11.4.7.3. Product Benchmarking
      • 11.4.7.4. Strategic Initiatives
    • 11.4.8. Cellular Engineering Technologies
      • 11.4.8.1. Overview
      • 11.4.8.2. Product Benchmarking
      • 11.4.8.3. Strategic Initiatives
    • 11.4.9. ATCC
      • 11.4.9.1. Overview
      • 11.4.9.2. Product Benchmarking
      • 11.4.9.3. Strategic Initiatives
    • 11.4.10. AcceGen
      • 11.4.10.1. Overview
      • 11.4.10.2. Product Benchmarking
      • 11.4.10.3. Strategic Initiatives
    • 11.4.11. Cell Applications, Inc.
      • 11.4.11.1. Overview
      • 11.4.11.2. Product Benchmarking
      • 11.4.11.3. Strategic Initiatives
    • 11.4.12. Bio-Techne
      • 11.4.12.1. Overview
      • 11.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 11.4.12.3. Product Benchmarking
      • 11.4.12.4. Strategic Initiatives

List of Tables

  • TABLE 1 List of Secondary Sources
  • TABLE 2 List of Abbreviations
  • TABLE 3 Global Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 4 Global Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 5 Global Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 6 Global Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 7 Global Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 8 Global Stem Cells Market, by Region, 2018 - 2030 (USD Million)
  • TABLE 9 North America Stem Cells Market, by Country, 2018 - 2030 (USD Million)
  • TABLE 10 North America Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 11 North America Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 12 North America Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 13 North America Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 14 North America Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 15 U.S. Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 16 U.S. Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 17 U.S. Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 18 U.S. Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 19 U.S. Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 20 Mexico Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 21 Mexico Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 22 Mexico Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 23 Mexico Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 24 Mexico Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 25 Canada Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 26 Canada Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 27 Canada Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 28 Canada Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 29 Canada Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 30 Europe Stem Cells Market, by Country, 2018 - 2030 (USD Million)
  • TABLE 31 Europe Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 32 Europe Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 33 Europe Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 34 Europe Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 35 Europe Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 36 Germany Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 37 Germany Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 38 Germany Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 39 Germany Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 40 Germany Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 41 UK Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 42 UK Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 43 UK Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 44 UK Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 45 UK Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 46 France Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 47 France Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 48 France Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 49 France Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 50 France Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 51 Italy Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 52 Italy Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 53 Italy Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 54 Italy Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 55 Italy Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 56 Spain Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 57 Spain Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 58 Spain Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 59 Spain Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 60 Spain Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 61 Denmark Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 62 Denmark Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 63 Denmark Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 64 Denmark Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 65 Denmark Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 66 Sweden Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 67 Sweden Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 68 Sweden Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 69 Sweden Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 70 Sweden Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 71 Norway Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 72 Norway Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 73 Norway Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 74 Norway Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 75 Norway Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 76 Asia Pacific Stem Cells Market, by Country, 2018 - 2030 (USD Million)
  • TABLE 77 Asia Pacific Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 78 Asia Pacific Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 79 Asia Pacific Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 80 Asia Pacific Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 81 Asia Pacific Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 82 China Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 83 China Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 84 China Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 85 China Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 86 China Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 87 Japan Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 88 Japan Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 89 Japan Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 90 Japan Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 91 Japan Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 92 India Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 93 India Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 94 India Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 95 India Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 96 India Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 97 South Korea Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 98 South Korea Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 99 South Korea Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 100 South Korea Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 101 South Korea Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 102 Australia Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 103 Australia Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 104 Australia Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 105 Australia Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 106 Australia Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 107 Thailand Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 108 Thailand Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 109 Thailand Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 110 Thailand Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 111 Thailand Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 112 Latin America Stem Cells Market, by Country, 2018 - 2030 (USD Million)
  • TABLE 113 Latin America Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 114 Latin America Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 115 Latin America Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 116 Latin America Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 117 Latin America Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 118 Brazil Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 119 Brazil Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 120 Brazil Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 121 Brazil Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 122 Brazil Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 123 Argentina Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 124 Argentina Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 125 Argentina Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 126 Argentina Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 127 Argentina Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 128 Middle East & Africa Stem Cells Market, by Country, 2018 - 2030 (USD Million)
  • TABLE 129 Middle East & Africa Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 130 Middle East & Africa Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 131 Middle East & Africa Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 132 Middle East & Africa Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 133 Middle East & Africa Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 134 South Africa Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 135 South Africa Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 136 South Africa Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 137 South Africa Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 138 South Africa Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
  • TABLE 139 Saudi Arabia Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 140 Saudi Arabia Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 141 Saudi Arabia Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 142 Saudi Arabia Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 143 Saudi Arabia Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 144 UAE Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 145 UAE Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 146 UAE Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 147 UAE Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 148 UAE Stem Cells Market, by End use, 2018 - 2030 (USD Million)
  • TABLE 149 Kuwait Stem Cells Market, by Product 2018 - 2030 (USD Million)
  • TABLE 150 Kuwait Stem Cells Market, by Application 2018 - 2030 (USD Million)
  • TABLE 151 Kuwait Stem Cells Market, by Technology 2018 - 2030 (USD Million)
  • TABLE 152 Kuwait Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
  • TABLE 153 Kuwait Stem Cells Market, by End use, 2018 - 2030 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information Procurement
  • FIG. 3 Primary Research Pattern
  • FIG. 4 Market Research Approaches
  • FIG. 5 Value Chain-Based Sizing & Forecasting
  • FIG. 6 Market Formulation & Validation
  • FIG. 7 Stem Cells Market Segmentation
  • FIG. 8 Market Snapshot, 2024
  • FIG. 9 Market Trends & Outlook
  • FIG. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • FIG. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • FIG. 12 PESTEL Analysis
  • FIG. 13 Porter's Five Forces Analysis
  • FIG. 14 Global Stem Cells Market: Product Movement Analysis
  • FIG. 15 Global Stem Cells Market, for Adult Stem Cells, 2018 - 2030 (USD Million)
  • FIG. 16 Global Stem Cells Market, for Hematopoietic Stem Cells (Blood Stem Cells), 2018 - 2030 (USD Million)
  • FIG. 17 Global Stem Cells Market, for Mesenchymal Stem Cells, 2018 - 2030 (USD Million)
  • FIG. 18 Global Stem Cells Market, for Neural Stem Cells, 2018 - 2030 (USD Million)
  • FIG. 19 Global Stem Cells Market, for Epithelial/Skin Stem Cells, 2018 - 2030 (USD Million)
  • FIG. 20 Global Stem Cells Market, for Other Adult Stem Cells, 2018 - 2030 (USD Million)
  • FIG. 21 Global Stem Cells Market, for Human Embryonic Stem Cells, 2018 - 2030 (USD Million)
  • FIG. 22 Global Stem Cells Market, for Induced Pluripotent Stem Cells, 2018 - 2030 (USD Million)
  • FIG. 23 Global Stem Cells Market, for Very Small Embryonic Like Stem Cells, 2018 - 2030 (USD Million)
  • FIG. 24 Global Stem Cells Market: Application Movement Analysis
  • FIG. 25 Global Stem Cells Market, for Regenerative Medicine, 2018 - 2030 (USD Million)
  • FIG. 26 Global Stem Cells Market, for Neurology, 2018 - 2030 (USD Million)
  • FIG. 27 Global Stem Cells Market, for Orthopedics, 2018 - 2030 (USD Million)
  • FIG. 28 Global Stem Cells Market, for Oncology, 2018 - 2030 (USD Million)
  • FIG. 29 Global Stem Cells Market, for Hematology, 2018 - 2030 (USD Million)
  • FIG. 30 Global Stem Cells Market, for Cardiovascular and Myocardial Infraction, 2018 - 2030 (USD Million)
  • FIG. 31 Global Stem Cells Market, for Injuries, 2018 - 2030 (USD Million)
  • FIG. 32 Global Stem Cells Market, for Diabetes, 2018 - 2030 (USD Million)
  • FIG. 33 Global Stem Cells Market, for Liver Disorder, 2018 - 2030 (USD Million)
  • FIG. 34 Global Stem Cells Market, for Incontinence, 2018 - 2030 (USD Million)
  • FIG. 35 Global Stem Cells Market, for Others, 2018 - 2030 (USD Million)
  • FIG. 36 Global Stem Cells Market, for Drug Discovery and Development, 2018 - 2030 (USD Million)
  • FIG. 37 Global Stem Cells Market: Technology Movement Analysis
  • FIG. 38 Global Stem Cells Market, for Cell Acquisition, 2018 - 2030 (USD Million)
  • FIG. 39 Global Stem Cells Market, for Bone Marrow Harvest, 2018 - 2030 (USD Million)
  • FIG. 40 Global Stem Cells Market, for Umbilical Blood Cord, 2018 - 2030 (USD Million)
  • FIG. 41 Global Stem Cells Market, for Apheresis, 2018 - 2030 (USD Million)
  • FIG. 42 Global Stem Cells Market, for Cell Production, 2018 - 2030 (USD Million)
  • FIG. 43 Global Stem Cells Market, for Therapeutic Cloning, 2018 - 2030 (USD Million)
  • FIG. 44 Global Stem Cells Market, for In Vitro Fertilization, 2018 - 2030 (USD Million)
  • FIG. 45 Global Stem Cells Market, for Cell Culture, 2018 - 2030 (USD Million)
  • FIG. 46 Global Stem Cells Market, for Isolation, 2018 - 2030 (USD Million)
  • FIG. 47 Global Stem Cells Market, for Cryopreservation, 2018 - 2030 (USD Million)
  • FIG. 48 Global Stem Cells Market, for Expansion and Sub-Culture, 2018 - 2030 (USD Million)
  • FIG. 49 Global Stem Cells Market: Therapy Movement Analysis
  • FIG. 50 Global Stem Cells Market, for Autologous, 2018 - 2030 (USD Million)
  • FIG. 51 Global Stem Cells Market, for Allogeneic, 2018 - 2030 (USD Million)
  • FIG. 52 Global Stem Cells Market, End-User Movement Analysis
  • FIG. 53 Global Stem Cells Market, for Pharmaceutical and Biotechnology Companies, 2018 - 2030 (USD Million)
  • FIG. 54 Global Stem Cells Market, for Hospitals & Cell Banks, 2018 - 2030 (USD Million)
  • FIG. 55 Global Stem Cells Market, for Academic & Research Institutes, 2018 - 2030 (USD Million)
  • FIG. 56 Regional Outlook, 2024 & 2030
  • FIG. 57 Global Stem Cells Market: Region Movement Analysis
  • FIG. 58 North America Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 59 U.S. Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 60 Canada Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 61 Europe Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 62 Germany Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 63 UK Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 64 France Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 65 Italy Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 66 Spain Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 67 Denmark Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 68 Norway Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 69 Sweden Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 70 Asia Pacific Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 71 Japan Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 72 China Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 73 India Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 74 Australia Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 75 South Korea Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 76 Thailand Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 77 Latin America Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 78 Brazil Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 79 Mexico Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 80 Argentina Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 81 Middle East and Africa Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 82 South Africa Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 83 Saudi Arabia Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 84 UAE Stem Cells Market, 2018 - 2030 (USD Million)
  • FIG. 85 Kuwait Stem Cells Market, 2018 - 2030 (USD Million)